By


VenatoRx Pharmaceuticals Awarded NIAID R01 Grant to Uncover Determinants of Gram-Negative Permeability
Leveraging a Unique Small Molecule Library, VenatoRx seeks to open challenging bottlenecks for antibacterial drug discovery and successfully introduce new antibacterial agents into the clinic 

See more here

By


Children’s of Alabama Selects Bainbridge Health to Support its Continued Commitment to Medication Safety and Stewardship
Bainbridge Health is partnering with Children’s of Alabama, ranked among the best pediatric medical centers in the nation by U.S. News and World report, to further bolster its efforts to improve medication safety and stewardship. 

See more here

By


ENB Therapeutics Announces Clinical Trial Collaboration with Merck to Evaluate ENB-003 in combination with KEYTRUDA(R) (pembrolizumab) for Advanced Solid Tumors

See more here

By


Group K Diagnostics Relocates to New Laboratory, Manufacturing and Office Space in Philadelphia

See more here

By


IView-1201 Phase II IND application for the Treatment of Adenoviral Conjunctivitis Accepted by US FDA

See more here

By


Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita
– Fast Track-Designated Program Commencing Phase 2/3 Study in Q1 2019 – 

See more here

By


Relmada Therapeutics Presents Clinical Data on Increased BDNF Plasma Levels in Subjects Treated with REL-1017
Findings on Effect of REL-1017 on BDNF Plasma Levels Presented at Annual Meeting of the American College of Neuropsychopharmacology 

See more here

By


CEO of Group K Diagnostics Nominated to the Philadelphia Startup Leaders Board

See more here